Category Archives: Lifestyle: Self Help

Self Help topics that will help you improve your outlook in the world, these PR articles will introduce the newest ways to help you grow personally.

Gateway Aesthetic Institute & Laser Center Announces Relocation to a New, Modern Facility


Since joining Dr. Taylor in 2019, Dr. Megan McClean has established herself as a leader and innovator in the field of laser and aesthetic dermatology. She is sought out for her expertise in enhancing her patients’ appearance through advanced combination therapies, taking into consideration the unique goals and preferences of each individual. Dr. McClean believes in ongoing maintenance and improvement through biostimulation and regenerative medicine and is highly skilled at achieving beautiful and natural results. She has pioneered several signature treatments at Gateway Aesthetic Institute and Laser Center, including the popular “Light and Bright” laser facial. She continues to be involved in academic inquiry, serving as an investigator in clinical trials for both cosmetic and medical dermatology, and publishing in international journals. As an invited monthly contributor to the “DermSurgery Digest” podcast, Dr. McClean is trusted to keep her colleagues abreast of the latest published advances in the field of cosmetic dermatology.

Dr. Kimberly Huerth has a particular interest in finding creative approaches to help patients with complex aesthetic concerns. For inspiration, she frequently travels internationally to learn from other aesthetic thought leaders and finds ways to incorporate a wide variety of advanced treatment approaches into her practice. Dr. Huerth seeks to integrate key principles from regenerative aesthetics, cutaneous biology, laser physics, and where appropriate, medical therapeutics, with her keen aesthetic eye and technical skill when carefully curating treatments for her patients. Dr. Huerth also contributes regularly to the dermatology literature, having authored chapters in three different authoritative aesthetic textbooks during the past few years, and serving as a member of the editorial board for the Journal of Drugs in Dermatology, a highly regarded publication that focuses on the latest advances in aesthetic and medical dermatology.

Completing this exceptional team is Dr. Donna Fischer, whose background in obstetrics and gynecology brings a unique perspective to the practice. She draws upon this expertise when performing laser-assisted labiaplasty, as well as a wide array of energy-based vaginal rejuvenation treatments. While she is skilled in many aesthetic procedures, Dr. Fischer is particularly sought after for her expertise in bioidentical hormone replacement therapy, semaglutide for medically supported weight loss, and liposuction.

Gateway Aesthetic Institute and Laser Center’s team of physicians and support staff have all expressed their unbridled enthusiasm for the relocation in 2024, as well as their continued commitment to providing exceptional care to patients. In a jointly issued statement, they declared, “Our team of highly experienced, specialty-trained physicians takes great joy in creating comprehensive, customized treatment plans for the patients we are privileged to serve. With our collective expertise and the advanced capabilities of our new facility, patients can trust that we will meticulously handle their well-being and safety while delivering beautiful aesthetic outcomes.”

Gateway Aesthetic Institute and Laser Center’s new location will be open for appointments and consultations in early 2024. For more information or to schedule an appointment at the current location (440 West 200 South, Suite 250 Salt Lake City, Utah 84101), please visit their website at www.gatewaylasercenter.com or call (801) 595-1600.

About Gateway Aesthetic Institute and Laser Center:

The physicians at Gateway Aesthetic Institute and Laser Center are known for performing a number of unique and highly sought-after specialty treatments, including laser resurfacing, laser eyelid surgery (blepharoplasty), laser-assisted torn or gauged earlobe repair, laser reshaping of rhinophyma (bulbous nose), laser ablation of benign skin lesions (including xanthelasma, sebaceous hyperplasia, seborrheic keratosis, skin tags, syringomas, milia, and others), laser treatments for pigmented and vascular birthmarks (including hemangiomas and port wine stains), sclerotherapy and laser treatment for varicose and spider veins (including those on the hands and face), laser and excisional removal of moles, medical and laser-directed therapy for a wide variety of pigmentary disorders, surgical and non-surgical treatments for cellulite, liposuction and fat transfer, and scalp and eyebrow hair transplants as well as non-surgical hair growth treatments. Gateway Aesthetic Institute and Laser Center also offers a wide variety of routine aesthetic treatments, such as injectables including neurotoxins (Botox, Dysport, Xeomin, Jeuveau, Daxxify) and soft tissue fillers (Restylane, Juvederm, Teoxane, Belotero, Sculptra, Radiesse), chemical peels, laser tattoo removal, laser hair removal, radiofrequency microneedling, and thread-lifts, among others. They also offer a robust selection of esthetician-led treatments.

Media Contact

Isabelle Geddes, Gateway Aesthetic Institute and Laser Center, 1 801-595-1600, [email protected], https://gatewaylasercenter.com/

Dr. Kimberly Huerth, Gateway Aesthetic Institute and Laser Center, 1 801-595-1600, [email protected], https://gatewaylasercenter.com/

SOURCE Gateway Aesthetic Institute and Laser Center

Richmond, TX’s, Fort Bend Dental is Selected as a 2023 Top Patient Rated Dentist by Find Local Doctors



At Fort Bend Dental, they have been providing southeast Texas with high-quality dental care for over three decades, offering services ranging from preventive care, emergency care, restorative and cosmetic dentistry.

RICHMOND, Texas, Oct. 23, 2023 /PRNewswire-PRWeb/ — Fort Bend Dental’s clinic, located at 7417 W Grand Pkwy S, Unit 140 in Richmond, TX, is a state-of-the-art facility that offers an expansive menu of quality dental care services for the entire family. As a result of the five-star ratings and exceptional online reviews the clinic has received, Find Local Doctors has recognized the Fort Bend Dental office in Richmond with this award. Find Local Doctors is a trusted online directory that helps consumers easily identify the best physicians and dentists in their area. Fort Bend Dental provides an unmatched level of comfortable, comprehensive, convenient and affordable oral health care. Covering all facets of modern dentistry, their dental practice is equipped with the latest in cutting-edge technology to provide treatments that patients will need throughout the years, such as same-day dentistry (including in-house CEREC® dental restorations), sedation dentistry, orthodontics, endodontics, smile makeovers, porcelain veneers, teeth whitening, implants, bridges and dentures. The clinic’s advanced treatments and attentive staff help patients of all ages attain healthy, balanced and beautiful smiles. The practice believes dental care should be accessible to everyone, and for those without insurance, they offer dental membership plan options.

TAR-200 Intravesical Delivery System Results Show 77 Percent Complete Response Rate in Patients with Bacillus-Calmette-Guérin Unresponsive, High-Risk Non-Muscle-Invasive Bladder Cancer


Phase 2b SunRISe-1 study results showed sustained, durable complete responses beyond one year with intravesical gemcitabine delivery system MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that data from the Phase 2b SunRISe-1…

Wellpointe Inc. Announces that its Co-Founder, President & CEO, George Kutnerian, Has Been Named a 2023 Future Leader by Aging Media


“The members of the Future Leaders Class of 2023 have demonstrated an exceptional commitment to enhancing the lives of seniors, families, and staff,” stated George Yedinak, Executive Vice President – Healthcare and Co-Founder of Aging Media. “Individually, they have displayed a remarkable dedication to transcending their everyday responsibilities and embracing a forward-thinking approach towards the future of aging.”

In its interview of Mr. Kutnerian, Senior Housing News caught up with him to discuss his time in the industry along with where he sees the industry headed, including the battle to attract top talent and the emergence of more distinct consumer segments with Mr. Kutnerian pointing to Wellpointe’s own pioneering of “small home” residential assisted living as an example of an innovative offering meeting the needs of an emerging consumer segment.

A full transcript of the interview can be found here.

Contact:

Joshua Lushtak – Chief of Staff

[email protected]

(559) 434-1839 ext 1090

About Aging Media and Senior Housing News

Aging Media Network is an innovative publishing company based in Chicago, Illinois, and is the publisher of Senior Housing News, Home Health Care News, Hospice News, Skilled Nursing News, and Behavioral Health Business. Senior Housing News (SHN) is the leading source for news and information covering the senior housing industry.

About Wellpointe Inc.

Operating at the intersection of healthcare and real estate, Wellpointe is a leading provider of boutique residential assisted living services that specializes in offering a coordinated and integrated system of care to high-acuity older adults with multiple chronic illnesses, including Alzheimer’s and other dementia.

Media Contact

Joshua Lushtak, Wellpointe Inc, 1 (559) 434-1839 1090, [email protected], www.wellpointe.com

SOURCE Wellpointe Inc

Mashup Media Launches New Hematology-Focused Brand, Heme Today


Innovative publisher of health care-focused platforms launches website dedicated to covering the latest news and advancements in blood disorders

MANALAPAN, N.J., Oct. 19, 2023 /PRNewswire-PRWeb/ — Mashup Media, LLC, fast-growing publisher of premier health care-focused platforms, is proud to announce the launch of Heme Today, a brand dedicated to delivering critical content related to blood disorders, including comprehensive coverage of cutting-edge research, the latest clinical trials, regulatory updates, and more.

Each year, millions of people worldwide are diagnosed with hematologic diseases, which have a negative effect on overall health. Covering these conditions is paramount, and Heme Today helps meet that need by publishing the latest news and advancements in the industry, ensuring health care providers have the information they need to optimize how they care for and educate their patients.

Heme Today joins Mashup Media’s portfolio, including Blood Cancers Today, that covers hematologic malignancies like leukemia. Heme Today will complement that site by focusing on blood diseases, such as anemia, hemophilia, sickle cell disease, von Willebrand disease, thrombotic and immune thrombocytopenic purpura, and more.

Heme Today is led by a team of experienced editors who curate timely, compelling, and well-researched written, video, and social media content. The brand, which also boasts a team of physician contributors and consultants, covers a range of topics, including:

  • Late-breaking research on therapies, devices, and clinical trials
  • Comprehensive coverage of conferences relevant to hematologic diseases
  • Commentary and insights from physicians, investigators, and educators
  • Feature articles and interviews with key opinion leaders and medical influencers

Heme Today joins a growing list of Mashup Media brands in addition to Blood Cancers Today—GU Oncology Now, DocWire News, Cancer Nursing Today, MashupMD, and Urban Health Today—that provide the engaging and educational content health care professionals rely on to enhance their capabilities and support positive patient outcomes.

“At Mashup Media, we believe our content keeps physicians informed and offers real-time thoughts and reactions from the health care providers who support patient care,” said JC Landry, CEO of Mashup Media. “Our suite of brands leads important conversations in the industry and provides information that resonates with our audience. The launch of Heme Today represents another step in our evolution and helps further solidify our mission to be a news source that health care professionals can trust.”

Learn more about Heme Today.

About Mashup Media

Mashup Media, LLC, based in Manalapan, N.J., is a multimedia publishing company passionate about providing health care professionals with a platform to further publicize their work. Driven by data and analytics, Mashup Media produces cutting-edge products that deliver content from trusted sources and industry thought leadership. To learn more, visit‥mashupmediallc.com.

Media Contact

Kerrie Keegan, Mashup Media, 1 646-894-2833, [email protected], https://mashupmediallc.com/ 

SOURCE Mashup Media

Chief Research Officer at US Fertility, Kate Devine, M.D., receives prestigious award from ASRM


The New Investigator Award is a highly competitive award that recognizes meritorious research conducted by an individual who is within 10 years of the completion of academic and professional training. The award was announced during ASRM’s Opening Ceremony on Monday, October 16, 2023 and presented during the ASRM Research Symposium on Wednesday, October 18, 2023.

“Dr. Devine has displayed a consistent and highly successful track record as a clinician-scientist performing and publishing important research that has significantly impacted the practice of reproductive endocrinology,” shares Michael A. Thomas, M.D., ASRM President.

“Dr. Devine defines the combination of clinician and researcher who devotes themselves to research to carry the field of reproductive medicine forward, allowing us to provide better care for our patients, and make a difference in the lives of so many,” shared Joseph Doyle, M.D., SGF physician, and Robert J. Stillman, M.D., SGF Medical Director Emeritus, in a letter of support for the award.

Dr. Devine is a board-certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. She serves as Associate Program Director to fellows at the National Institutes of Health (NIH) who are training to become reproductive endocrinologists and to residents training to become obstetricians/gynecologists at Georgetown School of Medicine and GW School of Medicine, where she serves as Clinical Professor. Dr. Devine also serves as the Medical Director and Chief Research Officer at US Fertility, Chair of the Society for Reproductive Endocrinology and Infertility (SREI) Research Committee, and Chair of the Society for Assisted Reproductive Technology (SART) Quality Assurance Committee.

Learn more about US Fertility’s Research Division, which conducts and publishes high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to infertility patients.

About US Fertility 

US Fertility, the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and by providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories. Visit http://www.USFertility.com for more information.

Media Contact

Chad Tulloch, US Fertility, 424-239-1088, [email protected], https://www.usfertility.com/

SOURCE US Fertility

Synterex Launches its AgileWriter™ Clinical Document Development Tool


AgileWriter can input a variety of source formats, extracting essential information and integrating rich biochemistry knowledge to craft documents in natural language while presenting information at a reading level suitable to the public. It is also one of the only medical communications tools built by design to adhere to the W3C® Authoring Tool Accessibility Guidelines (ATAG), maximizing the intersection between technology and accessibility.

“Plain language clinical and regulatory documents take time to generate—in some cases weeks—which is valuable time that clinical trial sponsors and sites need to get their study started,” said Synterex President Jeanette Towles. “AgileWriter can accelerate the document creation process, helping to get new treatments to patients faster and more efficiently. Every day a patient waits for a therapy they need is a day too long. Furthermore, for every day a drug is not on the market, it can cost a company millions of dollars; our tool can help companies reinvest that time and money into their R&D.”

AgileWriter evolves with each use, incorporating feedback to self-optimize. Its flexibility will extend to trial protocols, investigator brochures, data reports, and even regulatory submissions. It is an all-in-one tool designed for today’s demanding clinical landscape.

To learn more about the features of AgileWriter, click here: https://synterex.com/agilewriter/, or email [email protected].

For more information on Synterex and its leadership, visit: www.synterex.com.

About Synterex, Inc.:

Synterex is a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Delivering quality regulatory documentation requires navigating an evolving landscape influenced by regulators, research committees, healthcare professionals, and—most importantly—the scientific method itself.

At Synterex, we forge lasting and meaningful relationships that flex with the dynamic nature of science and technology.

Media Contact

Jeanette Towles, Synterex, 1 888-760-9906, [email protected], https://synterex.com/

SOURCE Synterex

Dedicated Medical Cannabis Clinic Opens in Hattiesburg, MS


TruReleaf MD brings to Mississippi a wealth of experience garnered over seven years of compassionate care in Florida under the name MMTCFL. As Medical Marijuana Treatment Clinics of Florida, they swiftly emerged as a cornerstone in the medical marijuana industry once medical cannabis was legalized for qualifying conditions. Their presence redefined the experience of being a medical marijuana patient, offering a natural relief option for those seeking care.

With this extensive background, TruReleaf MD aspires to rekindle the quality of life for patients through alternative treatments centered around cannabis. They firmly hold the belief that achieving relief is fundamental to regaining control over one’s life, and they are committed to equipping patients with the tools they need to make the best decisions for their own well-being.

Dr. Candace Thompson, a licensed Mississippi medical marijuana doctor, underscores the significance of this emerging industry, which promises natural alternatives to potent narcotics, ultimately aiming to curb the senseless loss of lives within the community. The clinic’s establishment provides patients with more opportunities to manage their conditions actively, propelling them closer to the life they aspire to lead.

Currently, the clinic offers in-person appointments for individuals with qualifying conditions. To schedule an appointment, patients can either visit www.getmymississippicard.com for online booking or contact 601-768-7944 to connect with a Patient Care Coordinator and schedule over the phone.

TruReleaf MD’s overarching mission is to promote public awareness and education regarding the safe access and responsible use of medical marijuana in Mississippi. Committed to adhering to state guidelines, they aim to streamline the process of obtaining a medical marijuana card, empowering patients to take charge of their healthcare journey.

Media Contact

Turner Davis, TruReleaf MD, 1 8134156465, [email protected], https://getmymississippicard.com/

SOURCE TruReleaf MD

EISAI TO PRESENT NEW DATA FROM LEQEMBI® (LECANEMAB-IRMB) PHASE 3 CLARITY AD STUDY AND OTHER ALZHEIMER'S DISEASE PIPELINE RESEARCH AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE


Update on LEQEMBI Investigational Subcutaneous Formulation TOKYO, Oct. 15, 2023 /PRNewswire/ — Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the company will present new data from the phase 3 Clarity AD study for its Alzheimer’s disease (AD)…